'RIL-Aramco stake sale talks stall over valuation, deal structure'

Chemical Weekly: Reliance Industries Ltd.’s talks to sell a minority stake in its refinery business to Saudi oil giant Aramco have hit a roadblock over valuation and deal structure, according to a Reuters report.
The talks concern Saudi Aramco interest in picking up to 25% stake in a proposed special purpose vehicle (SPV) housing the twin refine-ries of RIL as well as the firm’s petro-chemical complex. The Saudi firm is said to have disagreed with RIL over the transfer of some of the Rs. 2,88,243-crore group debt to the SPV.
However, a later report from Reuters quoted Saudi Arabia’s Energy Minister Khalid al-Falih as saying that Saudi Aramco’s talks with RIL have not stalled. “The two companies, Reliance and Aramco, are talking with a lot of goodwill, with good intention,” he told Reuters in an interview. He was ‘optimistic’ that a deal between the two companies would work out.
Reliance operates the world’s biggest refining complex with capacity to process 1.4 million barrels per day (bpd) of oil at Jamnagar. Aramco, the world’s biggest oil producer, plans to boost investment in refining and petro-chemicals to secure new markets for its crude amid a recent demand slowdown.
RIL has been selling assets – from mobile-phone towers to energy assets – to pare debt. The company’s plans to sell 25% of its refinery and petro-chemicals business could fetch at least $10-bn,Bloomberg News had reported in April. The sale would help pare the conglomerate’s obligations that have risen to about $42-bn, as it poured money into new sectors such as telecommunications.
Looking for chemical products? Let suppliers reach out to you!
2026-07-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Up to 25 billion! Saudi Aramco may acquire 20% of Reliance Industries
-
Powder coatings are used in many industries!
-
ECHEMI and CPHI China Jointly Host Pharmaceutical Business Match-making Event
-
CPHI China 2026 Concludes Successfully, ECHEMI Serves Global Pharmaceutical Clients
-
From API China to the Global Pharmaceutical Chain: ECHEMI Is Reshaping the "New Speed" of Pharmaceutical Trade
-
Review of the 93rd API China: In Chongqing, Witnessing the Global Pulse of the Pharmaceutical Industry
-
On the Second Day of the 93rd API China: ECHEMI Advances Global Dialogue in the Pharmaceutical Industry Through Innovative Practices
-
When Global Buyers Sit at the Same Table, Chinese Suppliers Respond: A Real 1-on-1 Online Business Matching Event
-
When Global Buyers No Longer Visit Trade Shows but “Select Suppliers with a Click”
-
72 Hours at API China: Where China’s API Export Industry Is Heading Next
Recommend Reading
-
ECHEMI WPO and Pharmaceutical Division Showcase Dual Strengths at the 94th API China, Tackling Pharmaceutical Export Challenges with Precision
-
Understand the New Rules to Enter the Market | ECHEMI × API China 2026 Overseas Pharmaceutical Market & Product Trends Conference Successfully Concluded
-
One Million Tonnes of U.S. Ethane Arrive as China Sets a New Import Record
-
Entering December, the domestic maleic anhydride market in China continues to decline
-
IEA Warns Oil Inventories Are Draining Fast as Chemicals Enter Risk Pricing
-
Phthalic Anhydride Prices Rebound and Rise in China
-
A $25 Billion Bill Hits Global Companies as Chemical Costs Are Repriced